Screening for perinatal depression is recommended internationally and should be a priority during an international public health crisis. Our study found that a higher percentage (28.4%) of Mexican women giving birth during the period of COVID-19 quarantine between February and July 2020 had PPD, as indicated by the EPDS score, compared with the frequency reported previously (13.3–18%) in Mexico. Similar results have been reported by Sun et al. who found that 33.71% of 2,883 women in Wuhan, China, had symptoms of depression [32]. These authors reported a relationship between COVID-19 and depression, and that 34% of the participants experienced depression during the 0–18-month postpartum period. Another study in China reported that, since the start of the COVID-19 pandemic, postpartum women had a higher incidence of anxiety and depression than women who were still pregnant. That study included 20,569 women, 16,796 of whom were pregnant and 3,722 were postpartum. The prevalence rate of depression among pregnant woman during the COVID-19 pandemic was 31% [14].
A study in Italy of 575 pregnant and postpartum women found that a large percentage of both groups had scores above the clinical cutoff for several well-being measures. The participants showed clinically significant depressive symptoms, 34.2% during pregnancy and 26.3% at postpartum [18], which suggests a significant global increase in the prevalence of depression during COVID-19. These findings suggest that the pandemic and measures adopted to fight its spread may have had negative effects on the well-being of pregnant and postpartum women. Social isolation, lack of support, and perceived lack of control over one’s health may negatively affect pregnancy outcomes [25]. Pregnant women giving birth during the COVID-19 pandemic represent a vulnerable population. High-risk groups should be carefully followed to minimize the risk of postpartum mental dysfunction, as previously reported following natural disasters [33].
SSC is an easy, simple, and cost-effective method and can be applied as a nursing intervention to encourage mother–infant bonding. SSC may have been effective at reducing PPD in the participants in our study given that a significantly higher percentage of women without PPD had initiated SSC after childbirth (P = 0.001). We also found that a higher percentage of mothers using SSC had a previous plan to feed their newborn with exclusive breastfeeding (P = 0.046) and to feed with exclusive breastfeeding during the first 48 h after birth (P = 0.004) than those mothers who did not initiate SSC. The application of SSC should be encouraged because it facilitates adaptations between mother and infant. Previous studies have shown that SSC contributes positively to reducing the incidence of PPD symptoms in mothers and term infants [26, 34, 35].
SSC is known to facilitate access to the breast and to increase breast milk production and breastfeeding rate. SSC also increases the breastfeeding rate and breastfeeding time after discharge from neonatal intensive care unit [36–38].
In a systematic review of 887 participants, Moore [36] et al. reported that women who initiated SSC were more likely to breastfeed at 1–4 months after birth than were those with standard contact. Women who initiate SSC also breastfeed their infants for longer and are more likely to breastfeed exclusively between the time of hospital discharge and 1 month later and between 6 weeks and 6 months after birth [36]. SSC may also reduce depressive feelings by strengthening the sense of motherhood [25, 39, 40]. Bigelow et al. [26] indicated that mother–infant SSC provided benefits by decreasing mothers’ depressive symptoms and physiological stress in the first weeks after birth. SSC can also improve general health and reduce symptoms of depression and stress in new mothers [25, 26, 35, 41].
The relationship between PPD and the practice of exclusive breastfeeding is not yet well established in the literature. However, this issue has been addressed in several studies because PPD may reduce the duration of exclusive breastfeeding [42]. Despite this observation, there is no consensus yet because some studies have reported that mothers with depressive symptoms are more likely to abandon the practice of exclusive breastfeeding [43, 44]. Using an EPDS score > 10 as the cutoff for PPD, Gaffney et al. [45] reported lower-intensity breastfeeding in mothers with depressive symptoms. The reason for this may be reduced self-efficacy in mothers with PPD because maternal confidence in breastfeeding tends to be affected by depressive symptoms [41]. Women with high self-esteem in the postpartum period tend to continue exclusive breastfeeding for longer than those with low self-esteem [46].
One of our study’s limitations is that there is no literature on PPD and BP based on the Mexican population to compare the results with a population similar to ours. Nonetheless, our data provide the basis for a better understanding of breastfeeding and PPD in postpartum women in Mexico. Another limitation is that our study included a smaller sample compared with previous research during COVID-19. More studies covering a larger population are needed to confirm our findings. One methodological limitation concerns the data collection because our data were collected online, which may affect the ability to compare with other studies using data collected in person. However, the digital survey has also been used in other studies [47, 48]. Although the online modality might discourage some women from seeking help, it helps in terms of anonymity and confidentiality.
The COVID-19 pandemic and resultant restrictions may aggravate symptoms of PPD. Health-care interventions may be needed to avoid deterioration of maternal health caused by social containment and after natural disasters [29].
To our knowledge, this is the first study to use the EPDS score to assess PPD in Mexican women giving birth in an area severely affected by COVID-19. The burden of exposure to COVID-19, physical distancing, and containment recommendations may adversely affect new mothers’ thoughts, emotions, and functioning, which may worsen their depressive symptoms. The present study used the EPDS scale because this population was regarded as a susceptible population. Despite the limitations noted above, the present results suggest that the pandemic emergency and restrictions imposed on the population have significantly affected the well-being of mothers during and after birth and that these effects may pose risks to mental health and emotional stability of new mothers.